Asarina Pharma AB (OSTO:ASAP) ROE % Adjusted to Book Value : -15.67% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Asarina Pharma AB ROE % Adjusted to Book Value?

Asarina Pharma AB's ROE % for the quarter that ended in Dec. 2023 was -188.86%. Asarina Pharma AB's PB Ratio for the quarter that ended in Dec. 2023 was 12.05. Asarina Pharma AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -15.67%.

Asarina Pharma AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Asarina Pharma AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asarina Pharma AB ROE % Adjusted to Book Value Chart

Asarina Pharma AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-14.50

-40.68

-49.92

-51.61

-13.10

Asarina Pharma AB Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial									-41.60	-55.46	-41.61	-52.78	-15.67

Competitive Comparison of Asarina Pharma AB's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Asarina Pharma AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asarina Pharma AB's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asarina Pharma AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Asarina Pharma AB's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Asarina Pharma AB ROE % Adjusted to Book Value Calculation

Asarina Pharma AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-157.86%	/	12.05
	=	-13.10%

Asarina Pharma AB's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-188.86%	/	12.05
	=	-15.67%

Asarina Pharma AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Asarina Pharma AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Asarina Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asarina Pharma AB (OSTO:ASAP) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fogdevreten 2, Karolinska Institutet Science Park, Solna, SWE, SE-171 65

Website

https://www.asarinapharma.com

Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.

Asarina Pharma AB Headlines

No Headlines